Prenez votre rendez-vous
Avis verifies des patients du centre de diagnostic DCDC a Dubai
Avis verifies et temoignages reels de patients de Dubai Healthcare City
Je suis très satisfaite de cette clinique médicale. J'ai fait mon premier dépistage de grossesse ici. C'était abordable et très professionnel. Le radiologue était accueillant, gentil et a rendu l'expérience formidable.
Aizhan Tokmanbetova
Je me suis blessée au genou vendredi soir et j'ai obtenu un rendez-vous IRM dimanche soir (réservé dimanche après-midi). J'ai attendu environ 2 minutes et c'était terminé en un peu plus de 30 minutes. L'équipe était incroyable, sympathique et efficace.
Kirsten Evans
L'équipe du Dr Osama était douce et incroyable. Après une mauvaise expérience ailleurs, mon examen pelvien ici était beaucoup plus professionnel. Excellent rapport et très précis.
Mary
CA-125 Blood Test in Dubai: Ovarian Cancer Marker Screening and Monitoring
Accurate CA-125 testing for ovarian cancer risk assessment, pelvic symptom evaluation, and treatment response monitoring
Precise Measurement
Advanced immunoassay for accurate CA-125 quantification
Clinical Context
Results interpreted by gynaecologists within your full health profile
Fast Results
Most CA-125 results available within 24-48 hours
Specialist Pathway
Direct referral to gynaecology for abnormal findings and further evaluation
CA-125, or Cancer Antigen 125, is a protein biomarker that is elevated in the blood of many women with ovarian cancer. Ovarian cancer is often called the silent killer because it typically presents with vague, non-specific symptoms that are easily attributed to other conditions, and by the time it is diagnosed, the disease has frequently advanced to later stages where treatment outcomes are less favourable. The CA-125 blood test, when used appropriately in the right clinical context, serves as a valuable tool for risk assessment, diagnostic support, treatment monitoring, and recurrence detection. Understanding both its strengths and limitations is essential for informed healthcare decisions.
At DCDC, we offer CA-125 testing as both a standalone marker and as part of comprehensive panels for women's health evaluation. The test measures the concentration of CA-125 protein in the blood, with levels below 35 units per millilitre generally considered normal. However, CA-125 is not exclusively produced by ovarian cancer cells. It is also found on the surface of normal cells in the fallopian tubes, endometrium, peritoneum, pleura, and pericardium, which means that various benign conditions can also cause elevations. This dual nature makes clinical interpretation essential and is why CA-125 should always be evaluated by a qualified physician within the full clinical context.
Precise Measurement
Advanced immunoassay for accurate CA-125 quantification
Clinical Context
Results interpreted by gynaecologists within your full health profile
Fast Results
Most CA-125 results available within 24-48 hours
Specialist Pathway
Direct referral to gynaecology for abnormal findings and further evaluation
CA-125 Blood Test in Dubai: Ovarian Cancer Marker Screening and Monitoring
Accurate CA-125 testing for ovarian cancer risk assessment, pelvic symptom evaluation, and treatment response monitoring
CA-125, or Cancer Antigen 125, is a protein biomarker that is elevated in the blood of many women with ovarian cancer. Ovarian cancer is often called the silent killer because it typically presents with vague, non-specific symptoms that are easily attributed to other conditions, and by the time it is diagnosed, the disease has frequently advanced to later stages where treatment outcomes are less favourable. The CA-125 blood test, when used appropriately in the right clinical context, serves as a valuable tool for risk assessment, diagnostic support, treatment monitoring, and recurrence detection. Understanding both its strengths and limitations is essential for informed healthcare decisions.
At DCDC, we offer CA-125 testing as both a standalone marker and as part of comprehensive panels for women's health evaluation. The test measures the concentration of CA-125 protein in the blood, with levels below 35 units per millilitre generally considered normal. However, CA-125 is not exclusively produced by ovarian cancer cells. It is also found on the surface of normal cells in the fallopian tubes, endometrium, peritoneum, pleura, and pericardium, which means that various benign conditions can also cause elevations. This dual nature makes clinical interpretation essential and is why CA-125 should always be evaluated by a qualified physician within the full clinical context.
Dr. Hadi Komshi
Nos services CA-125 Test
Services ca-125 test complets au DCDC Dubai Healthcare City.
CA-125 Screening
Ovarian cancer marker blood test for risk assessment and symptom evaluation.
CA-125 Monitoring
Serial testing for treatment response tracking and recurrence surveillance.
Pelvic Mass Evaluation
CA-125 combined with ultrasound findings for ovarian mass risk stratification.
Women's Cancer Screening Panel
CA-125 alongside other relevant markers for comprehensive women's cancer assessment.
Tous les services realises par des specialistes agrees DHA
Qui devrait beneficier de CA-125 Test ?
CA-125 testing is recommended for women with symptoms suggestive of ovarian pathology, those with significant family history of ovarian or breast cancer, and patients requiring treatment monitoring for diagnosed ovarian cancer or endometriosis.
Persistent bloating lasting more than two weeks without clear cause
Pelvic or abdominal pain that is new, persistent, or unexplained
Difficulty eating or feeling full quickly with unexplained weight changes
Urinary urgency or frequency without urinary tract infection
Family history of ovarian, breast, or endometrial cancer
Known BRCA1 or BRCA2 gene mutation carriers
Votre visite en tout confort
Un processus d'examen CA-125 simple, etape par etape, concu pour le confort, la rapidite et la precision.
Test Pricing
Les tarifs CA-125 à Dubaï varient selon le type de service et la couverture d'assurance pour différents types de tests.
- Les tarifs varient selon le type d'examen et la necessite de produit de contraste
- Couverture d'assurance acceptee avec ordonnance et verification
- Tarifs transparents pour paiement direct avec devis instantane sur demande
Verification d'assurance en quelques minutes - Pas de frais caches - Reponse rapide sur WhatsApp
Guide du patient
Your Lab Test Experience
Quick, comfortable, and straightforward.
Assurance et localisation
Partenaires d'assurance
- •Plus de 20 assureurs à Dubaï dont Daman, AXA, ADNIC et d'autres
- •Assistance pré-autorisation et facturation directe (le cas échéant)
- •Vérification de la couverture avant votre rendez-vous dans notre clinique de Dubai Healthcare City
- •Tarification transparente sans frais cachés pour les services de ca-125 test
Rendez-nous visite a Dubai Healthcare City
Doctors Clinic Diagnostic Center
Batiment 64, Bloc A, Al Razi Medical Complex, Dubai Healthcare City, Dubai, EAU
Pres de Oud Metha Road - Acces facile depuis Bur Dubai, Downtown Dubai, Business Bay - Parking gratuit dedie disponible
Horaires d'ouverture
Lun-Jeu, Sam : 8h - 22h30 | Dim : 8h30 - 22h30 | Ven : 9h - 22h
Comment fonctionne l'assurance chez DCDC
VĂ©rifier la couverture
VĂ©rifiez que votre plan couvre CA-125 Test
Obtenir une référence
Certains assureurs exigent une référence du médecin — nous pouvons vous guider
Pré-autorisation
Nous gérons la pré-autorisation directement avec votre assureur
Facturation directe
Pas de paiement initial — nous facturons directement votre assureur
Co-paiement uniquement
Vous ne payez que le co-paiement applicable Ă la clinique
VĂ©rifier la couverture
VĂ©rifiez que votre plan couvre CA-125 Test
Obtenir une référence
Certains assureurs exigent une référence du médecin — nous pouvons vous guider
Pré-autorisation
Nous gérons la pré-autorisation directement avec votre assureur
Facturation directe
Pas de paiement initial — nous facturons directement votre assureur
Co-paiement uniquement
Vous ne payez que le co-paiement applicable Ă la clinique
Votre spécialiste
Dr. Hadi Komshi
Specialist Internal Medicine
MD, Specialist Internal Medicine
Persan · Arabe · Anglais
Conditions and Cancers Assessed Through CA-125 Testing
Epithelial Ovarian Cancer
The most common type of ovarian cancer, with CA-125 elevated in approximately 80 percent of advanced cases and 50 percent of early-stage disease.
Fallopian Tube Cancer
Primary fallopian tube carcinoma, now recognised as closely related to high-grade serous ovarian cancer, with similar CA-125 elevation patterns.
Primary Peritoneal Cancer
Peritoneal carcinomatosis arising from peritoneal surfaces, sharing histology and CA-125 marker behaviour with epithelial ovarian cancer.
Endometriosis
Chronic pelvic condition frequently causing CA-125 elevation proportional to disease severity, useful for monitoring treatment response.
Services connexes
Decouvrez d'autres services de diagnostic et de consultation disponibles dans notre clinique de Dubai Healthcare City.
Questions frequentes
Questions courantes sur CA-125 Test a Dubai.
CA-125 is a glycoprotein normally expressed on cells lining the ovaries, fallopian tubes, endometrium, and peritoneum. Ovarian cancer cells produce significantly increased quantities, causing blood levels to rise above the normal threshold of 35 U/mL.
Yes, very commonly. In premenopausal women, 90 percent of CA-125 elevations are benign.
No. Major guidelines do not recommend CA-125 for general population screening due to limited sensitivity for early-stage cancer and high false-positive rates in premenopausal women.
During chemotherapy, declining CA-125 correlates with tumour response; normalization below 35 U/mL is associated with improved survival. CA-125 half-life below 14 days predicts better outcomes.
CA-125 is frequently elevated in endometriosis, correlating with disease severity. Mild disease may cause modest increases to 35-50 U/mL; severe disease with endometriomas can exceed 100-200 U/mL.
Faits cles
Supervision medicale
Tous les services sont fournis sous la supervision de professionnels medicaux agrees dans notre etablissement accredite MOHAP.